Unknown

Dataset Information

0

Syntheses and crystal structure of 4-[(pyridin-3-yl)diazen-yl]morpholine and 1-[(pyridin-3-yl)diazen-yl]-1,2,3,4-tetra-hydro-quinoline.


ABSTRACT: Two new heterocyclic 1,2,3-triazenes were synthesized by diazo-tation of 3-amino-pyridine following respectively by coupling with morpholine or 1,2,3,4-tetra-hydro-quinoline. 4-[(Pyridin-3-yl)diazen-yl]morpholine (I), C9H12N4O, has monoclinic P21/c symmetry at 100 K, while 1-[(pyridin-3-yl)diazen-yl]-1,2,3,4-tetra-hydro-quinoline (II), C14H14N4, has monoclinic P21/n symmetry at 100 K. These 1,2,3-triazene derivatives were synthesized by the organic medium method by coupling reactions of 3-amino-pyridine with morpholine and 1,2,3,4-tetra-hydro-quinoline, respectively, and characterized by 1H NMR, 13C NMR, IR, mass spectrometry, and single-crystal X-ray diffraction. The mol-ecule of compound I consists of pyridine and morpholine rings connected by an azo moiety (-N=N-). In the mol-ecule of II, the pyridine ring and the 1,2,3,4-tetra-hydro-quinoline unit are also connected by an azo moiety. The double- and single-bond distances in the triazene chain are comparable for the two compounds. In both crystal structures, the mol-ecules are connected by C-H⋯N inter-actions, forming infinite chains for I and layers parallel to the bc plane for II.

SUBMITTER: Sokhna S 

PROVIDER: S-EPMC9912458 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Syntheses and crystal structure of 4-[(pyridin-3-yl)diazen-yl]morpholine and 1-[(pyridin-3-yl)diazen-yl]-1,2,3,4-tetra-hydro-quinoline.

Sokhna Seynabou S   Seck Insa I   Thiam Ibrahima El Hadj IEH   Presset Marc M   Ndoye Samba Fama SF   Ba Lalla Aïcha LA   Samb Issa I   Coles Simon S   Orton James J   Seck Matar M   Le Gall Erwan E   Gaye Mohamed M   Gaye Mohamed M  

Acta crystallographica. Section E, Crystallographic communications 20230110 Pt 2


Two new heterocyclic 1,2,3-triazenes were synthesized by diazo-tation of 3-amino-pyridine following respectively by coupling with morpholine or 1,2,3,4-tetra-hydro-quinoline. 4-[(Pyridin-3-yl)diazen-yl]morpholine (<b>I</b>), C<sub>9</sub>H<sub>12</sub>N<sub>4</sub>O, has monoclinic <i>P</i>2<sub>1</sub>/<i>c</i> symmetry at 100 K, while 1-[(pyridin-3-yl)diazen-yl]-1,2,3,4-tetra-hydro-quinoline (<b>II</b>), C<sub>14</sub>H<sub>14</sub>N<sub>4</sub>, has monoclinic <i>P</i>2<sub>1</sub>/<i>n</i> s  ...[more]

Similar Datasets

| S-EPMC4459366 | biostudies-literature
| S-EPMC4331909 | biostudies-literature
| S-EPMC4438803 | biostudies-literature
| S-EPMC7057357 | biostudies-literature
| S-EPMC3201410 | biostudies-literature
| S-EPMC4257240 | biostudies-other
| S-EPMC3885068 | biostudies-literature
| S-EPMC3589024 | biostudies-other
| S-EPMC2960691 | biostudies-literature
| S-EPMC3295520 | biostudies-literature